Associated Papers
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.
Bahar ME et al.
Signal Transduction and Targeted Therapy, 2023
BRAF mutations and concurrent alterations in patients with soft tissue sarcoma.
Kobayashi H et al.
Genes, Chromosomes & Cancer, 2023
Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group.
Vranic S et al.
Acta Medica Academica, 2022
Ongoing progress in BRAF-mutated non-small cell lung cancer.
Abdayem P et al.
Clinical Advances in Hematology & Oncology : H&o, 2022
RAF-MEK-ERK pathway in cancer evolution and treatment.
Ullah R et al.
Seminars in Cancer Biology, 2022
BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors.
Talloa D et al.
Cancers, 2022
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes.
Di Federico A et al.
Cancers, 2022
Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions.
Riudavets M et al.
Lung Cancer (amsterdam, Netherlands), 2022
Melanoma with genetic alterations beyond the BRAFV600 mutation: management and new insights.
Awada G et al.
Current Opinion in Oncology, 2022
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Hescheler DA et al.
Frontiers in Endocrinology, 2021
Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks.
Śmiech M et al.
Genes, 2020
Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study.
Lei L et al.
Translational Cancer Research, 2020
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.
Yao Z et al.
Nature, 2017
A Braf kinase-inactive mutant induces lung adenocarcinoma.
Nieto P et al.
Nature, 2017
BRAF mutation testing in clinical practice.
Ziai J et al.
Expert Review of Molecular Diagnostics, 2012
The energy landscape analysis of cancer mutations in protein kinases.
Dixit A et al.
Plos One, 2011
Development and applications of a BRAF oligonucleotide microarray.
Kim IJ et al.
The Journal of Molecular Diagnostics : Jmd, 2007
BRAF mutation detection and identification by cycling temperature capillary electrophoresis.
Hinselwood DC et al.
Electrophoresis, 2005